Spruce Biosciences, Inc.(SPRB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SPRB Spruce Biosciences, Inc.

交易中 08-16 12:24:23 EDT

0.4590

+0.0191

+4.34%

最高0.4659	最低0.4413	成交量23.06万
今开0.4413	昨收0.4399	日振幅5.59%
总市值1,896万	流通市值1,140万	总股本4,130万
成交额10.57万	换手率0.93%	流通股本2,483万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SPRB","market":"US","secType":"STK","nameCN":"Spruce Biosciences, Inc.","latestPrice":0.459,"timestamp":1723825352693,"preClose":0.4399,"halted":0,"volume":230580,"delay":0,"floatShares":24834550,"shares":41302599,"eps":-1.052718,"marketStatus":"交易中","marketStatusCode":2,"change":0.0191,"latestTime":"08-16 12:24:23 EDT","open":0.4413,"high":0.4659,"low":0.4413,"amount":105710.86287720001,"amplitude":0.055922,"askPrice":0.4599,"askSize":200,"bidPrice":0.4581,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.052718,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1723838400000},"adr":0,"listingDate":1602216000000,"adjPreClose":0.4399,"preHourTrading":{"tag":"盘前","latestPrice":0.438,"preClose":0.4399,"latestTime":"09:13 EDT","volume":11992,"amount":5223.2693374400005,"timestamp":1723814023020},"postHourTrading":{"tag":"盘后","latestPrice":0.4399,"preClose":0.4399,"latestTime":"19:57 EDT","volume":80,"amount":35.1585,"timestamp":1723766223198},"volumeRatio":0.981508,"impliedVol":1.1441,"impliedVolPercentile":0.475},"requestUrl":"/m/hq/s/SPRB/wiki","defaultTab":"wiki","newsList":[{"id":"2459210367","title":"Spruce Biosciences, Inc.盘中异动 早盘急速上涨5.02%报0.462美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459210367","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459210367?lang=zh_cn&edition=full","pubTime":"2024-08-16 21:53","pubTimestamp":1723816422,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日21时53分，Spruce Biosciences, Inc.股票出现波动，股价快速拉升5.02%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Cingulate Inc.、Seelos Therapeutics, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Cingulate Inc.、Seelos Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为3553.50%、1415.74%、143.89%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Seelos Therapeutics, Inc.、Cingulate Inc.，振幅分别为100.53%、36.81%、35.42%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081621534397198f63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081621534397198f63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2459906472","title":"Spruce Biosciences, Inc.2024财年第二财季实现净利润-9.18百万美元，同比增加28.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459906472","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459906472?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:03","pubTimestamp":1723737823,"startTime":"0","endTime":"0","summary":"8月16日，Spruce Biosciences, Inc.公布财报，公告显示公司2024财年第二财季净利润为-9.18百万美元，同比增加28.39%；其中营业收入为1.61百万美元，同比减少25.81%，每股基本收益为-0.22美元。从资产负债表来看，Spruce Biosciences, Inc.总负债16.35百万美元，其中短期债务1.89百万美元，资产负债比为4.62，流动比率为5.18。机构评级：截至2024年8月16日，当前有4家机构对Spruce Biosciences, Inc.目标价做出预测，其中目标均价为2.50美元，其中最低目标价为2.00美元，最高目标价为3.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000350959be73d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000350959be73d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB"],"gpt_icon":0},{"id":"2459040289","title":"Spruce Biosciences, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459040289","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459040289?lang=zh_cn&edition=full","pubTime":"2024-08-13 22:08","pubTimestamp":1723558104,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日22时08分，Spruce Biosciences, Inc.股票出现异动，股价快速拉升5.00%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.33%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813220824aefe9fa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813220824aefe9fa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2459699387","title":"斯普鲁斯生物科学公司公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2459699387","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459699387?lang=zh_cn&edition=full","pubTime":"2024-08-13 08:50","pubTimestamp":1723510201,"startTime":"0","endTime":"0","summary":"   * Spruce Biosciences Inc   报告，截至6月底的季度调整后每股亏损22美分，高于去年同期的每股-32美分。七位分析师对该季度的平均预期是每股亏损 32 美分。华尔街预期为每股-35美分至-29美分。* 收入为 161 万美元，同比下降 25.6%；分析师预期为 150 万美元。* 斯普鲁斯生物科学公司公布的本季度每股收益为亏损22美分。* Spruce Biosciences Inc 本季度股价下跌了 15.5%，今年迄今为止下跌了 85.1%。华尔街对 Spruce Biosciences Inc 的 12 个月目标价中位数为 2.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"斯普鲁斯生物科学公司公布截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRB"],"gpt_icon":0},{"id":"2459693431","title":"Spruce Biosciences, Inc.盘中异动 下午盘股价大跌5.12%报0.415美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459693431","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459693431?lang=zh_cn&edition=full","pubTime":"2024-08-13 01:35","pubTimestamp":1723484124,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日01时35分，Spruce Biosciences, Inc.股票出现波动，股价急速跳水5.12%。截至发稿，该股报0.415美元/股，成交量35.4254万股，换手率0.86%，振幅7.75%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.81%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813013525942000ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813013525942000ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2458180425","title":"Spruce Biosciences Inc    预计每股亏损 32 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458180425","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458180425?lang=zh_cn&edition=full","pubTime":"2024-08-09 23:52","pubTimestamp":1723218745,"startTime":"0","endTime":"0","summary":"* LSEG分析师对Spruce Biosciences Inc的平均预期是每股亏损32美分。* 华尔街对 Spruce Biosciences Inc 的 12 个月目标价中位数为 2.50 美元，高于上一次 0.44 美元的收盘价。8月9日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Spruce Biosciences Inc    预计每股亏损 32 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRB"],"gpt_icon":0},{"id":"2457987936","title":"Spruce Biosciences, Inc.盘中异动 临近收盘急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457987936","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457987936?lang=zh_cn&edition=full","pubTime":"2024-08-08 03:36","pubTimestamp":1723059379,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日03时36分，Spruce Biosciences, Inc.股票出现波动，股价大幅下挫5.00%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为2.49%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、G1 Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Aditxt, Inc.、Salarius Pharmaceuticals, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为5229.44%、2824.69%、326.10%，振幅较大的相关个股有Aditxt, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为101.30%、69.66%、66.67%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808033620971989a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808033620971989a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2453885748","title":"Spruce Biosciences, Inc.盘中异动 早盘快速拉升5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453885748","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453885748?lang=zh_cn&edition=full","pubTime":"2024-07-24 22:26","pubTimestamp":1721831190,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日22时26分，Spruce Biosciences, Inc.股票出现波动，股价大幅上涨5.22%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Dermata Therapeutics, Inc.、Pieris Pharmaceuticals, Inc.、Dermata Therapeutics Inc C/Wts 涨幅较大，Dermata Therapeutics, Inc.、Azitra Inc、Gri Bio, Inc.较为活跃，换手率分别为7128.31%、1099.65%、604.73%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Sangamo Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts ，振幅分别为181.54%、94.69%、72.79%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724222631af93e926&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724222631af93e926&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2452161892","title":"Spruce Biosciences, Inc.盘中异动 临近午盘大幅跳水5.08%报0.560美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452161892","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452161892?lang=zh_cn&edition=full","pubTime":"2024-07-17 23:39","pubTimestamp":1721230741,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日23时39分，Spruce Biosciences, Inc.股票出现异动，股价大幅下挫5.08%。截至发稿，该股报0.560美元/股，成交量23.0756万股，换手率0.56%，振幅5.76%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为2.03%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717233902af92cd17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717233902af92cd17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2450810570","title":"Spruce Biosciences, Inc.盘中异动 大幅跳水5.50%报0.533美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450810570","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450810570?lang=zh_cn&edition=full","pubTime":"2024-07-11 00:07","pubTimestamp":1720627631,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日00时07分，Spruce Biosciences, Inc.股票出现波动，股价快速跳水5.50%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.00%。其相关个股中，Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为3840.14%、1416.13%、1037.68%，振幅较大的相关个股有Kazia Therapeutics Limited、Revolution Medicines Inc C/Wts 17/12/2026 、Virpax Pharmaceuticals, Inc.，振幅分别为421.88%、133.16%、119.83%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711000712aef9014f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711000712aef9014f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2448482666","title":"Spruce Biosciences, Inc.盘中异动 股价大涨5.23%报0.555美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448482666","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448482666?lang=zh_cn&edition=full","pubTime":"2024-07-03 23:34","pubTimestamp":1720020888,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日23时34分，Spruce Biosciences, Inc.股票出现波动，股价大幅上涨5.23%。截至发稿，该股报0.555美元/股，成交量9.3658万股，换手率0.23%，振幅3.96%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.26%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703233448aef7cd19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703233448aef7cd19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2446876745","title":"Spruce Biosciences, Inc.盘中异动 临近收盘股价大涨5.24%报0.568美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446876745","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446876745?lang=zh_cn&edition=full","pubTime":"2024-06-26 03:44","pubTimestamp":1719344650,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日03时44分，Spruce Biosciences, Inc.股票出现异动，股价快速拉升5.24%。截至发稿，该股报0.568美元/股，成交量29.2257万股，换手率0.71%，振幅4.87%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.28%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626034410af8f249b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626034410af8f249b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2445072894","title":"Spruce Biosciences, Inc.盘中异动 大幅上涨5.27%报0.540美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445072894","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445072894?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:40","pubTimestamp":1719236458,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时40分，Spruce Biosciences, Inc.股票出现异动，股价快速上涨5.27%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624214058941f0919&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624214058941f0919&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2444210359","title":"Spruce Biosciences, Inc.盘中异动 大幅下跌6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444210359","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444210359?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:50","pubTimestamp":1718891406,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时50分，Spruce Biosciences, Inc.股票出现异动，股价快速跳水6.06%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620215006af8e74ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620215006af8e74ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2444466976","title":"根据资产购买协议Spruce Biosciences将以1000万美元的价格（基于特定情况）从Eiger收购转让资产。","url":"https://stock-news.laohu8.com/highlight/detail?id=2444466976","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444466976?lang=zh_cn&edition=full","pubTime":"2024-06-19 05:25","pubTimestamp":1718745957,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2444092465","title":"Spruce Biosciences公司：6月13日公司已签署“先期收购”资产购买协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2444092465","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444092465?lang=zh_cn&edition=full","pubTime":"2024-06-19 05:13","pubTimestamp":1718745184,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2443059056","title":"Spruce Biosciences, Inc.盘中异动 股价大跌5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443059056","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443059056?lang=zh_cn&edition=full","pubTime":"2024-06-15 01:30","pubTimestamp":1718386210,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日01时30分，Spruce Biosciences, Inc.股票出现异动，股价快速下跌5.55%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Effector Therapeutics Inc C/Wts 31/12/2025 、Nkgen Biotech Inc C/Wts 31/05/2028、Longeveron Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Longeveron Inc.、Bio-Path Holdings, Inc.较为活跃，换手率分别为2203.13%、1348.15%、262.45%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Scinai Immunotherapeutics Ltd，振幅分别为129.28%、60.25%、58.87%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615013011aef50d0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615013011aef50d0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2439674658","title":"Spruce Biosciences, Inc.盘中异动 下午盘股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439674658","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439674658?lang=zh_cn&edition=full","pubTime":"2024-05-31 03:16","pubTimestamp":1717096610,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日03时16分，Spruce Biosciences, Inc.股票出现异动，股价急速上涨5.15%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Summit Therapeutics Inc.、Nkgen Biotech Inc C/Wts 31/05/2028、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Kintara Therapeutics, Inc.、Mustang Bio, Inc.、Onconetix, Inc.较为活跃，换手率分别为134.53%、74.66%、67.04%，振幅较大的相关个股有Summit Therapeutics Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Calidi Biotherapeutics, Inc.，振幅分别为237.48%、104.00%、93.84%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531031650941eb409&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531031650941eb409&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2439505173","title":"Spruce Biosciences, Inc.盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439505173","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439505173?lang=zh_cn&edition=full","pubTime":"2024-05-30 01:29","pubTimestamp":1717003781,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日01时29分，Spruce Biosciences, Inc.股票出现异动，股价急速拉升5.09%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.84%。其相关个股中，Onconetix, Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Mustang Bio, Inc.、Onconetix, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为520.54%、138.58%、110.47%，振幅较大的相关个股有Onconetix, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为127.15%、117.00%、50.40%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530012941af8af205&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530012941af8af205&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2435160595","title":"HC Wainwright &amp; Co.：重申Spruce Biosciences(SPRB.US)中性评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435160595","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435160595?lang=zh_cn&edition=full","pubTime":"2024-05-14 18:22","pubTimestamp":1715682138,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","SPRB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sprucebiosciences.com","stockEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":-0.2544},{"period":"3month","weight":-0.4135},{"period":"6month","weight":-0.9124},{"period":"1year","weight":-0.8018},{"period":"ytd","weight":-0.8499}],"compareEarnings":[{"period":"1week","weight":0.0423},{"period":"1month","weight":-0.0209},{"period":"3month","weight":0.0446},{"period":"6month","weight":0.1072},{"period":"1year","weight":0.258},{"period":"ytd","weight":0.1636}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Spruce Biosciences, Inc.最初于2014年11月在特拉华州成立为一家有限责任公司。该公司是一家处于后期阶段的生物制药公司，专注于开发和商业化治疗罕见的内分泌疾病的新疗法，这些疾病的医疗需求尚未得到满足。该公司正在初步开发全资候选产品tildacerfont，作为潜在的第一个非甾体疗法，为患有典型先天性肾上腺增生症的患者提供显著改善的疾病控制和减少类固醇负担。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.33989},{"month":2,"riseRate":0.5,"avgChangeRate":0.009378},{"month":3,"riseRate":0,"avgChangeRate":-0.297383},{"month":4,"riseRate":0,"avgChangeRate":-0.078867},{"month":5,"riseRate":0.5,"avgChangeRate":-0.003763},{"month":6,"riseRate":0.25,"avgChangeRate":-0.126985},{"month":7,"riseRate":0.5,"avgChangeRate":-0.017508},{"month":8,"riseRate":0.25,"avgChangeRate":-0.033139},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.195471},{"month":10,"riseRate":0,"avgChangeRate":-0.297781},{"month":11,"riseRate":0.5,"avgChangeRate":0.017474},{"month":12,"riseRate":0.5,"avgChangeRate":0.416923}],"exchange":"NASDAQ","name":"Spruce Biosciences, Inc.","nameEN":"Spruce Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Spruce Biosciences, Inc.(SPRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Spruce Biosciences, Inc.(SPRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Spruce Biosciences, Inc.,SPRB,Spruce Biosciences, Inc.股票,Spruce Biosciences, Inc.股票老虎,Spruce Biosciences, Inc.股票老虎国际,Spruce Biosciences, Inc.行情,Spruce Biosciences, Inc.股票行情,Spruce Biosciences, Inc.股价,Spruce Biosciences, Inc.股市,Spruce Biosciences, Inc.股票价格,Spruce Biosciences, Inc.股票交易,Spruce Biosciences, Inc.股票购买,Spruce Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Spruce Biosciences, Inc.(SPRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Spruce Biosciences, Inc.(SPRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}